| 000 | 01638 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514061140.0 | ||
| 264 | 0 | _c20030414 | |
| 008 | 200304s 0 0 eng d | ||
| 022 | _a0969-7128 | ||
| 024 | 7 |
_a10.1038/sj.gt.3301897 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYamaguchi, T | |
| 245 | 0 | 0 |
_aEnhancement of thymidine kinase-mediated killing of malignant glioma by BimS, a BH3-only cell death activator. _h[electronic resource] |
| 260 |
_bGene therapy _cMar 2003 |
||
| 300 |
_a375-85 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenoviridae _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aApoptosis _xgenetics |
| 650 | 0 | 4 |
_aBrain Neoplasms _xtherapy |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGanciclovir _xtherapeutic use |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 |
_aGenetic Vectors _xadministration & dosage |
| 650 | 0 | 4 |
_aGlioma _xtherapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aSimplexvirus _xenzymology |
| 650 | 0 | 4 |
_aThymidine Kinase _xgenetics |
| 650 | 0 | 4 |
_aTransduction, Genetic _xmethods |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aOkada, T | |
| 700 | 1 | _aTakeuchi, K | |
| 700 | 1 | _aTonda, T | |
| 700 | 1 | _aOhtaki, M | |
| 700 | 1 | _aShinoda, S | |
| 700 | 1 | _aMasuzawa, T | |
| 700 | 1 | _aOzawa, K | |
| 700 | 1 | _aInaba, T | |
| 773 | 0 |
_tGene therapy _gvol. 10 _gno. 5 _gp. 375-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.gt.3301897 _zAvailable from publisher's website |
| 999 |
_c12397849 _d12397849 |
||